世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Molecular Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global molecular breast imaging (MBI) market is set to witness substantial growth, expanding at a CAGR of 6.95% between 2025 and 2032. The market, projected to reach USD 890.86 million by 2025 ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global molecular breast imaging (MBI) market is set to witness substantial growth, expanding at a CAGR of 6.95% between 2025 and 2032. The market, projected to reach USD 890.86 million by 2025 and USD 1,425.91 million by 2032, is driven by technological advancements and an increasing focus on early breast cancer detection. Molecular breast imaging is gaining traction as a crucial diagnostic tool, particularly for patients with dense breast tissue, enhancing early cancer detection and reducing false positives.Market Insights Molecular breast imaging is a specialized diagnostic technique that utilizes a radioactive tracer to highlight cellular activity in breast tissues. Unlike traditional mammography, MBI provides functional and metabolic insights, improving accuracy in diagnosing breast cancer. The rising incidence of breast cancer and continuous advancements in medical imaging are propelling the demand for MBI technology. Ongoing research and development efforts are further expected to enhance imaging precision, boosting market adoption globally. Key Market Drivers 1. Technological Advancements in Imaging – Innovations such as digital detectors and sophisticated image-processing algorithms enhance the sensitivity and resolution of MBI, improving diagnostic accuracy. 2. Increasing Focus on Personalized Medicine – MBI is becoming integral to tailored treatment approaches, allowing healthcare professionals to develop personalized cancer treatment plans. 3. Growing Awareness and Screening Programs – Increased government and healthcare initiatives promoting breast cancer screening are driving the market forward. 4. Rising Breast Cancer Prevalence – The escalating number of breast cancer cases globally necessitates advanced imaging solutions like MBI. Business Opportunities 1. Expansion Beyond Breast Cancer Detection – MBI’s potential for diagnosing other types of cancers and medical conditions presents new growth opportunities for manufacturers. 2. Integration with Artificial Intelligence (AI) – AI-powered diagnostic tools can analyze MBI images more efficiently, leading to improved detection accuracy and workflow optimization. 3. Partnerships and Collaborations – Strategic alliances between MBI manufacturers and AI technology firms can drive market differentiation and innovation. Market Restraints 1. Regulatory and Safety Challenges – The use of radioactive tracers necessitates strict regulatory compliance, potentially delaying new product launches. 2. High Costs and Limited Accessibility – The high initial investment and operational costs of MBI systems may hinder adoption, especially in resource-limited regions. 3. Geographical Disparities – Unequal distribution of healthcare infrastructure restricts access to advanced diagnostic tools in remote and underserved areas. Regional Analysis • North America remains the dominant region, driven by advanced healthcare infrastructure, high breast cancer awareness, and rapid adoption of cutting-edge medical technologies. • East Asia is the fastest-growing region, fueled by healthcare modernization, increasing breast cancer prevalence, and strong government initiatives. • Europe, Latin America, and the Middle East & Africa are also witnessing steady market growth, supported by expanding healthcare investments and technological advancements. Key Players Leading companies in the molecular breast imaging market are focusing on R&D, product innovation, and strategic collaborations to maintain their market position. Notable players include: • Koninklijke Philips N.V. (Netherlands) • Hitachi Ltd. (Japan) • Siemens Healthcare GmbH (Germany) • CANON MEDICAL SYSTEMS CORPORATION (Japan) • General Electric (US) • Aspect Imaging Ltd (Israel) • Bruker (US) • Aurora Health Care (US) • FONAR Corp. (US) • ESAOTE SPA (Italy) • Neusoft Corporation (China) • TOSHIBA CORPORATION (Japan) Market Segmentation 1. By Modality: o Single Head Gamma Camera o Dual Head Camera 2. By Imaging Technique: o Planar Imaging o SPECT Imaging 3. By Application: o Screening o Diagnosis o Others (Research & Development) 4. By End User: o Hospitals o Diagnostic Imaging Centers o Breast Cancer Care Facilities 5. By Region: o North America o Europe o Asia Pacific o Latin America o Middle East & Africa Table of Contents1. Executive Summary1.1. Global Molecular Breast Imaging Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Molecular Breast Imaging Market Outlook, 2019 - 2032 3.1. Global Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032 3.1.1. Key Highlights 3.1.1.1. Single Head Gamma Camera 3.1.1.2. Dual Head Camera 3.2. Global Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032 3.2.1. Key Highlights 3.2.1.1. Planar Imaging 3.2.1.2. SPECT Imaging 3.3. Global Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032 3.3.1. Key Highlights 3.3.1.1. Screening 3.3.1.2. Diagnosis 3.3.1.3. Others (such as research and development) 3.4. Global Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032 3.4.1. Key Highlights 3.4.1.1. Hospital 3.4.1.2. Diagnostic Imaging Centers 3.4.1.3. Breast Cancer Care 3.5. Global Molecular Breast Imaging Market Outlook, by Region, Value (US$ Mn), 2019 - 2032 3.5.1. Key Highlights 3.5.1.1. North America 3.5.1.2. Europe 3.5.1.3. Asia Pacific 3.5.1.4. Latin America 3.5.1.5. Middle East & Africa 4. North America Molecular Breast Imaging Market Outlook, 2019 - 2032 4.1. North America Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032 4.1.1. Key Highlights 4.1.1.1. Single Head Gamma Camera 4.1.1.2. Dual Head Camera 4.2. North America Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032 4.2.1. Key Highlights 4.2.1.1. Planar Imaging 4.2.1.2. SPECT Imaging 4.3. North America Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032 4.3.1. Key Highlights 4.3.1.1. Screening 4.3.1.2. Diagnosis 4.3.1.3. Others (such as research and development) 4.4. North America Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032 4.4.1. Key Highlights 4.4.1.1. Hospital 4.4.1.2. Diagnostic Imaging Centers 4.4.1.3. Breast Cancer Care 4.5. North America Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032 4.5.1. Key Highlights 4.5.1.1. U.S. Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 4.5.1.2. U.S. Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 4.5.1.3. U.S. Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 4.5.1.4. U.S. Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 4.5.1.5. Canada Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 4.5.1.6. Canada Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 4.5.1.7. Canada Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 4.5.1.8. Canada Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 4.5.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Molecular Breast Imaging Market Outlook, 2019 - 2032 5.1. Europe Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032 5.1.1. Key Highlights 5.1.1.1. Single Head Gamma Camera 5.1.1.2. Dual Head Camera 5.2. Europe Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.2.1. Key Highlights 5.2.1.1. Planar Imaging 5.2.1.2. SPECT Imaging 5.3. Europe Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032 5.3.1. Key Highlights 5.3.1.1. Screening 5.3.1.2. Diagnosis 5.3.1.3. Others (such as research and development) 5.4. Europe Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032 5.4.1. Key Highlights 5.4.1.1. Hospital 5.4.1.2. Diagnostic Imaging Centers 5.4.1.3. Breast Cancer Care 5.5. Europe Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032 5.5.1. Key Highlights 5.5.1.1. Germany Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.2. Germany Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.3. Germany Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.4. Germany Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.1.5. U.K. Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.6. U.K. Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.7. U.K. Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.8. U.K. Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.1.9. France Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.10. France Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.11. France Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.12. France Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.1.13. Italy Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.14. Italy Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.15. Italy Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.16. Italy Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.1.17. Turkey Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.18. Turkey Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.19. Turkey Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.20. Turkey Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.1.21. Russia Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.22. Russia Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.23. Russia Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.24. Russia Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.1.25. Rest of Europe Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 5.5.1.26. Rest of Europe Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 5.5.1.27. Rest of Europe Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 5.5.1.28. Rest of Europe Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 5.5.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Molecular Breast Imaging Market Outlook, 2019 - 2032 6.1. Asia Pacific Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032 6.1.1. Key Highlights 6.1.1.1. Single Head Gamma Camera 6.1.1.2. Dual Head Camera 6.2. Asia Pacific Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.2.1. Key Highlights 6.2.1.1. Planar Imaging 6.2.1.2. SPECT Imaging 6.3. Asia Pacific Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032 6.3.1. Key Highlights 6.3.1.1. Screening 6.3.1.2. Diagnosis 6.3.1.3. Others (such as research and development) 6.4. Asia Pacific Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032 6.4.1. Key Highlights 6.4.1.1. Hospital 6.4.1.2. Diagnostic Imaging Centers 6.4.1.3. Breast Cancer Care 6.5. Asia Pacific Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032 6.5.1. Key Highlights 6.5.1.1. China Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 6.5.1.2. China Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.5.1.3. China Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 6.5.1.4. China Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 6.5.1.5. Japan Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 6.5.1.6. Japan Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.5.1.7. Japan Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 6.5.1.8. Japan Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 6.5.1.9. South Korea Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 6.5.1.10. South Korea Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.5.1.11. South Korea Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 6.5.1.12. South Korea Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 6.5.1.13. India Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 6.5.1.14. India Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.5.1.15. India Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 6.5.1.16. India Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 6.5.1.17. Southeast Asia Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 6.5.1.18. Southeast Asia Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.5.1.19. Southeast Asia Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 6.5.1.20. Southeast Asia Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 6.5.1.21. Rest of Asia Pacific Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 6.5.1.22. Rest of Asia Pacific Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 6.5.1.23. Rest of Asia Pacific Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 6.5.1.24. Rest of Asia Pacific Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 6.5.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Molecular Breast Imaging Market Outlook, 2019 - 2032 7.1. Latin America Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032 7.1.1. Key Highlights 7.1.1.1. Single Head Gamma Camera 7.1.1.2. Dual Head Camera 7.2. Latin America Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032 7.2.1.1. Planar Imaging 7.2.1.2. SPECT Imaging 7.3. Latin America Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032 7.3.1. Key Highlights 7.3.1.1. Screening 7.3.1.2. Diagnosis 7.3.1.3. Others (such as research and development) 7.4. Latin America Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032 7.4.1. Key Highlights 7.4.1.1. Hospital 7.4.1.2. Diagnostic Imaging Centers 7.4.1.3. Breast Cancer Care 7.5. Latin America Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032 7.5.1. Key Highlights 7.5.1.1. Brazil Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 7.5.1.2. Brazil Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 7.5.1.3. Brazil Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 7.5.1.4. Brazil Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 7.5.1.5. Mexico Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 7.5.1.6. Mexico Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 7.5.1.7. Mexico Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 7.5.1.8. Mexico Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 7.5.1.9. Argentina Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 7.5.1.10. Argentina Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 7.5.1.11. Argentina Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 7.5.1.12. Argentina Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 7.5.1.13. Rest of Latin America Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 7.5.1.14. Rest of Latin America Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 7.5.1.15. Rest of Latin America Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 7.5.1.16. Rest of Latin America Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 7.5.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Molecular Breast Imaging Market Outlook, 2019 - 2032 8.1. Middle East & Africa Molecular Breast Imaging Market Outlook, by Modality, Value (US$ Mn), 2019 - 2032 8.1.1. Key Highlights 8.1.1.1. Single Head Gamma Camera 8.1.1.2. Dual Head Camera 8.2. Middle East & Africa Molecular Breast Imaging Market Outlook, by Imaging Technique, Value (US$ Mn), 2019 - 2032 8.2.1. Key Highlights 8.2.1.1. Planar Imaging 8.2.1.2. SPECT Imaging 8.3. Middle East & Africa Molecular Breast Imaging Market Outlook, by Application, Value (US$ Mn), 2019 - 2032 8.3.1. Key Highlights 8.3.1.1. Screening 8.3.1.2. Diagnosis 8.3.1.3. Others (such as research and development) 8.4. Middle East & Africa Molecular Breast Imaging Market Outlook, by End User, Value (US$ Mn), 2019 - 2032 8.4.1. Key Highlights 8.4.1.1. Hospital 8.4.1.2. Diagnostic Imaging Centers 8.4.1.3. Breast Cancer Care 8.5. Middle East & Africa Molecular Breast Imaging Market Outlook, by Country, Value (US$ Mn), 2019 - 2032 8.5.1. Key Highlights 8.5.1.1. GCC Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 8.5.1.2. GCC Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 8.5.1.3. GCC Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 8.5.1.4. GCC Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 8.5.1.5. South Africa Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 8.5.1.6. South Africa Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 8.5.1.7. South Africa Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 8.5.1.8. South Africa Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 8.5.1.9. Egypt Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 8.5.1.10. Egypt Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 8.5.1.11. Egypt Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 8.5.1.12. Egypt Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 8.5.1.13. Nigeria Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 8.5.1.14. Nigeria Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 8.5.1.15. Nigeria Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 8.5.1.16. Nigeria Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 8.5.1.17. Rest of Middle East & Africa Molecular Breast Imaging Market by Modality, Value (US$ Mn), 2019 - 2032 8.5.1.18. Rest of Middle East & Africa Molecular Breast Imaging Market by Imaging Technique, Value (US$ Mn), 2019 - 2032 8.5.1.19. Rest of Middle East & Africa Molecular Breast Imaging Market by Application, Value (US$ Mn), 2019 - 2032 8.5.1.20. Rest of Middle East & Africa Molecular Breast Imaging Market by End User, Value (US$ Mn), 2019 - 2032 8.5.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. by Application vs by Imaging Technique Heat map 9.2. Manufacturer vs by Imaging Technique Heat map 9.3. Company Market Share Analysis, 2025 9.4. Competitive Dashboard 9.5. Company Profiles 9.5.1. Koninklijke Philips N.V. 9.5.1.1. Company Overview 9.5.1.2. Product Portfolio 9.5.1.3. Financial Overview 9.5.1.4. Business Strategies and Development 9.5.2. Hitachi Ltd. 9.5.3. Siemens Healthcare GmbH 9.5.4. CANON MEDICAL SYSTEMS CORPORATION 9.5.5. General Electric 9.5.6. Aspect Imaging Ltd 9.5.7. Bruker 9.5.8. Aurora Health Care 9.5.9. FONAR Corp. 9.5.10. ESAOTE SPA 9.5.11. Neusoft Corporation 9.5.12. TOSHIBA CORPORATION 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社のヘルスケアIT分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
